Search company, investor...


Founded Year



Other Investors | Alive

About Camrivox

Camrivox is an technology leader delivering products for unifying telephony with On Demand CRM applications. Focused on small and mid-sized businesses, the company's Flexor family of CTI products aims to provide a simple way to integrate telephony with applications at the desktop bypassing costly system and equipment upgrades. Flexor CTI for Outlook is now available as a free download for Asterisk or snom users.

Headquarters Location

The Jeffreys Building St John's Innovation Park

CB4 0WS,

United Kingdom

Missing: Camrivox's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Camrivox's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Camrivox Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Camrivox Rank

Camrivox Frequently Asked Questions (FAQ)

  • When was Camrivox founded?

    Camrivox was founded in 2005.

  • What is Camrivox's latest funding round?

    Camrivox's latest funding round is Other Investors.

  • Who are the investors of Camrivox?

    Investors of Camrivox include Oxfordshire Investment Opportunity Network, Create Partners, CREATE East of England Fund, Nesta, IQ Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.